Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-320c: Hsa-mir-320c is a microRNA present in plasma extracellular vesicles (EVs) that has been associated with disease progression in certain clinical contexts [PMC8121992]. It has been found that hsa-mir-320c, along with hsa-miR-320d and hsa-miR-320b, is significantly upregulated in patients with progressive disease (PD) compared to those exhibiting a partial response (PR) to immunotherapy, suggesting its potential utility as a biomarker for monitoring treatment response [PMC8121992]. However, while hsa-mir-320c was significantly differentially expressed, it was not identified as one of the most significant microRNAs when applying stringent criteria for differential expression (logCPM>4, p<0.05, FDR≤0.1); instead, hsa-miR-320d and hsa-miR-642a-3p were noted as the most significant in the study [PMC7057418].
mRNA interactions
24 total
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset
